A multicentre, phase III, randomised controlled trial of radiotherapy and concomitant Temodal (temozolomide) or neoadjuvant chemotherapy followed by radiotherapy and concomitant Temodal in patients with high grade glioma.
Phase of Trial: Phase III
Latest Information Update: 20 Sep 2011
At a glance
- Drugs Temozolomide (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma
- Focus Therapeutic Use
- 20 Sep 2011 Additional lead trial center identified as reported by ISRCTN.
- 30 Sep 2010 New trial record